Home › Chronic Kidney Disease › Florida › Fort Lauderdale
Chronic Kidney Disease clinical trials in Fort Lauderdale, FL
3 studies for Chronic Kidney Disease are looking for participants at sites in and around Fort Lauderdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Fort Lauderdale
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
RecruitingPhase 3
- Research Site, Fort Lauderdale
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
RecruitingPhase 3
- Research Site, Fort Lauderdale
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY17 studies
- Boston, MA15 studies
- Houston, TX15 studies
- Dallas, TX15 studies
- Philadelphia, PA15 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA10 studies
- Durham, NC9 studies
- Kansas City, MO9 studies
- San Antonio, TX8 studies
- Albuquerque, NM8 studies
Other studies in Fort Lauderdale
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Heart Failure6 studies
- Macular Degeneration5 studies
- Ovarian Cancer4 studies
- Breast Cancer4 studies
- Multiple Myeloma3 studies
- Blood Cancers3 studies
- Cardiovascular Disease3 studies
- Colon Cancer3 studies
- Colorectal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.